🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
144,67 USD
Máx. histórico
156,45
70 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-7,53%
Rango 52 semanas
82,01 – 156,92
Variación hoy
-2,49%
Cierre anterior
148,36
Rango de hoy
143,47 – 147,62
Volumen hoy
8.862.415
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,42%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 146,13 (puede no estar actualizado)
- Dividend yield
- 2,29% (puede no estar actualizado)
- Precio objetivo analistas
- 160,29 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 16 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/01/2023 | 111,59 | 113,91 | 111,42 | 113,64 | +1,39% | 2,23% | 9.578.900 |
| 04/01/2023 | 112,32 | 112,61 | 111,24 | 112,08 | +0,85% | 1,22% | 8.698.600 |
| 03/01/2023 | 110,41 | 111,20 | 109,49 | 111,14 | +0,17% | 1,55% | 8.062.500 |
| 30/12/2022 | 111,23 | 111,42 | 110,12 | 110,95 | +0,12% | 1,17% | 5.498.600 |
| 29/12/2022 | 111,39 | 111,70 | 110,75 | 110,82 | -0,23% | 0,85% | 4.467.200 |
| 28/12/2022 | 112,89 | 112,89 | 111,06 | 111,08 | -0,93% | 1,62% | 5.107.800 |
| 27/12/2022 | 112,41 | 112,59 | 111,53 | 112,12 | +0,23% | 0,94% | 5.125.800 |
| 23/12/2022 | 111,25 | 112,13 | 110,87 | 111,86 | +0,56% | 1,13% | 4.547.400 |
| 22/12/2022 | 110,90 | 111,69 | 110,21 | 111,24 | +0,12% | 1,33% | 8.373.700 |
| 21/12/2022 | 110,10 | 111,19 | 109,54 | 111,11 | +1,28% | 1,50% | 6.640.900 |
| 20/12/2022 | 109,94 | 110,66 | 109,16 | 109,71 | +0,25% | 1,36% | 8.022.000 |
| 19/12/2022 | 109,19 | 110,10 | 108,77 | 109,44 | +0,22% | 1,22% | 6.949.500 |
| 16/12/2022 | 109,24 | 109,70 | 108,27 | 109,20 | -0,39% | 1,31% | 29.465.900 |
| 15/12/2022 | 110,24 | 110,77 | 109,23 | 109,63 | -1,72% | 1,40% | 9.871.400 |
| 14/12/2022 | 110,52 | 112,17 | 110,04 | 111,55 | +0,58% | 1,93% | 10.788.300 |
| 13/12/2022 | 111,26 | 111,26 | 109,00 | 110,91 | +1,78% | 2,03% | 15.836.900 |
| 12/12/2022 | 107,93 | 109,10 | 107,32 | 108,97 | +0,17% | 1,65% | 10.956.600 |
| 09/12/2022 | 110,98 | 111,37 | 108,75 | 108,78 | -1,87% | 2,36% | 9.667.800 |
| 08/12/2022 | 110,28 | 111,02 | 110,12 | 110,85 | +0,69% | 0,82% | 7.354.800 |
| 07/12/2022 | 109,15 | 110,71 | 109,00 | 110,09 | +1,06% | 1,57% | 8.270.400 |
| 06/12/2022 | 110,36 | 110,76 | 108,42 | 108,93 | -0,98% | 2,12% | 7.458.700 |
| 05/12/2022 | 109,81 | 110,23 | 109,21 | 110,01 | -0,03% | 0,93% | 6.961.900 |
| 02/12/2022 | 109,00 | 110,09 | 108,71 | 110,04 | +0,22% | 1,27% | 6.943.600 |
| 01/12/2022 | 109,75 | 110,98 | 108,77 | 109,80 | -0,29% | 2,01% | 10.110.500 |
| 30/11/2022 | 108,70 | 110,33 | 107,63 | 110,12 | +1,18% | 2,48% | 20.305.800 |
| 29/11/2022 | 108,00 | 109,06 | 107,55 | 108,84 | +0,36% | 1,40% | 9.352.400 |
| 28/11/2022 | 107,13 | 108,90 | 107,13 | 108,45 | +0,88% | 1,65% | 9.524.500 |
| 25/11/2022 | 106,56 | 107,50 | 106,56 | 107,50 | +0,64% | 0,88% | 3.163.700 |
| 23/11/2022 | 106,75 | 107,30 | 106,30 | 106,82 | -0,07% | 0,94% | 5.749.600 |
| 22/11/2022 | 106,13 | 107,10 | 106,05 | 106,90 | +1,22% | 0,99% | 8.295.700 |